ArticleiGIE : innovation, investigation and insights2025
Unveiling the effectiveness of Chat-GPT 4.0, an artificial intelligence conversational tool, for addressing common patient queries in gastrointestinal endoscopy.
Article in iGIE : innovation, investigation and insights, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Reliability of Human Evaluation of Large Language Models in Health Care Settings: Scoping Review.Journal of medical Internet research · 2026Article
- Gut Instincts, Machine Decisions: Evaluating AI Accuracy in the Diagnosis and Treatment of Disorders of Gut-Brain Interaction.Neurogastroenterology and motility · 2026Article
- When AI speaks like a specialist: ChatGPT-4 in the management of inflammatory bowel disease.Frontiers in artificial intelligence · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Chat Generative Pre-Trained Transformer (Chat-GPT) has proven effective in addressing patient inquiries related to gastrointestinal (GI) disease. We aimed to assess the effectiveness and reliability of Chat-GPT in answering common patients' queries on GI endoscopy. Methods: Eighteen selected patients' queries regarding GI endoscopy were rated on a Likert-type scale by 10 health professionals and 2 non-health professionals on the following features: reliability (1-6), accuracy (1-3), and comprehensibility (1-3). Results: The mean reliability, accuracy, and comprehensibility values were 5.2 ± 1.7, 2.7 ± 0.4, and 2.9 ± 0.2, respectively. Overall, most answers were rated as having a solid level of reliability (94.4%) and accuracy (100%) and fair levels of comprehensibility (61.1%). The physicians considered the tool to be adequate for addressing questions related to clinical practice, except for inquiries regarding bowel prep solutions, medications, and pacemaker management. Conclusions: Chat-GPT 4.0 demonstrated effectiveness in providing patients with informative content about GI endoscopy, even though health professional support remains essential for a comprehensive approach.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.